Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) has announced what it called “ground-breaking achievements” in the realm of mental health detection and analysis, having successfully developed functionalities through innovative artificial intelligence (AI) solutions to detect depression, anxiety, and analyze individual mood and emotions.
The provider of rapid health screening solutions powered by proprietary AI said it has developed advanced functionality to detect signs of depression and anxiety through its state-of-the-art AI algorithms, which addresses the critical need for early identification and intervention in mental health.
"The culmination of over 250,000 individual scans is a testament to the real-world impact of our technology," Predictmedix AI chief operating officer Dr Rahul Kushwah said in a statement.
"As machine learning accuracy continues to improve, we are dedicated to advancing innovation in health and safety applications for the benefit of individuals and communities," he added.
Predictmedix AI noted its technology has successfully implemented functionalities to detect and analyze individual mood and emotions, offering a comprehensive understanding of an individual's mental well-being, going beyond traditional diagnostics.
Predictmedix AI is an emerging provider of rapid health screening and remote patient care solutions globally. Its Safe Entry Stations - powered by a proprietary AI - use multispectral cameras to analyze physiological data patterns and predict a variety of health issues, including 19 physiological vital parameters, impairment by drugs or alcohol, fatigue, or various mental illnesses.
Contact Sean at sean@proactiveinvestors.com